1.Serratia marcescens Spinal Epidural Abscess Following Caudal Epidural Injection.
Chang Eon YU ; Byeong Yeol CHOI ; Kyung Tae KIM ; Young Chul PARK
The Journal of the Korean Orthopaedic Association 2017;52(4):359-363
Spinal infection due to Serratia marcescens is very rare. A 78-year-old male patient withoutany risk factor was admitted to our hospital with chief complaints of severe back pain, fever, weakness in both legs, and bowel dysfunction, following caudal epidural injection. Magnetic resonance imaging revealed spondylodiscitis with epidural abscess. Surgical decompression was performed and the epidural abscess was removed. The cultures isolated S. marcescens, which can cause nosocomial infection in immunocompromised patient. However, to the best of our knowledge, we report the first case of S. marcescens spinal epidural abscess following epidural injection, with literature review.
Aged
;
Back Pain
;
Cross Infection
;
Decompression, Surgical
;
Discitis
;
Epidural Abscess*
;
Fever
;
Humans
;
Immunocompromised Host
;
Injections, Epidural*
;
Leg
;
Magnetic Resonance Imaging
;
Male
;
Risk Factors
;
Serratia marcescens*
;
Serratia*
2.Morphological Variation of the Kidney Secondary to Junctional Parenchyma on Ultrasound.
Ji Yoon LEE ; Byeong Ho PARK ; Kyeong Jin NAM ; Jong Cheol CHOI ; Bong Sig KOO ; Jou Yeoung KIM ; Seung Eon AHN ; Yung Il LEE
Journal of the Korean Radiological Society 1996;34(4):527-531
PURPOSE: To evaluate the prevalance of morphological variation of the kidney secondary to junctional parenchyma, as well as to analyze the ultrasonographic features of junctional parenchyma. MATERIALS AND METHODS: Two hundred and eighty two kidneys of 141 patient without clinical or radiologic evidence of renal disease were prospectively analysed using ultrasound. In all patients, ultrasonograms were obtained in sagittal, coronal and transaxial planes. The kidney was considered to have morphological variation if the ulrasonogram demonstrated junctional parenchymal defect or line ; those showing such variation were classified as one of three types :continuous, discontinuous, or junctional parenchymal line or defect without junctional parenchyma. The prevalance and ultrasonographic features of the kidneys were evaluated. RESULTS: Morphological variation was noted in 71 cases(25%). the continuous type accounted for 54% of these, the discontinuous type for 38%, and junctional parenchymal defect or line without junctional parenchyma for 8%. In all cases, junctional parenchyma was located approximately at the junction of the upper and middle third of the kidny, and had the same echogenecity as the renal cortex. CONCLUSION: An understanding of the morphological variation of the kidney resulting from junctional renal parenchyma would be helpful in differentiating pseudo tumor from true renal neoplasm.
Humans
;
Kidney Neoplasms
;
Kidney*
;
Ultrasonography*
3.The Influence of Depression and School Life on the Quality of Life of Korean Child and Adolescent Patients with Attention-Deficit/Hyperactivity Disorder: A Comparison of the Perspectives of the Patients and Their Caregivers
Byeong Eon PARK ; Jeong Seop LEE ; Hee Yun KIM ; Jae Nam BAE ; Won Hyoung KIM ; Hye Young KIM ; Mi Roo RIM ; Sang Gu KANG ; Seo Hyun CHOI
Journal of the Korean Academy of Child and Adolescent Psychiatry 2019;30(1):2-8
OBJECTIVES: This study aimed to compare the quality of life reported by patients with attention-deficit/hyperactivity disorder (ADHD) to the patients' quality of life as reported by their caregivers. In addition, it aimed to examine how emotional problems, including depression and anxiety, and the severity of the symptoms affect the quality of life reported by the patients and their caregivers. METHODS: The patients' quality of life and their degree of depression and anxiety were measured using the Pediatric Quality of Life Inventory (PedsQL) 4.0 Child Self-Report, the Children's Depression Inventory (CDI), and the Revised Children's Manifest Anxiety Scale, respectively. The caregivers' perception of the patients' quality of life and severity of the ADHD symptoms were measured using the PedsQL 4.0 Parent Proxy Report and the Conners' Parent Rating Scale (CPRS), respectively. A total of 66 participants completed the survey. The independent-samples t-test, Pearson's correlation analysis, and multiple regression analysis were conducted. RESULTS: The mean score of the PedsQL 4.0 Child Self-Report was significantly higher than the mean score of the PedsQL 4.0 Parent Proxy Report. However, for school function, the PedsQL 4.0 Child Self-Report score was significantly lower than that of Parent Proxy Report. The correlation between the PedsQL 4.0 Child Self-Report and PedsQL 4.0 Parent Proxy Report scores was significant only for emotional function and social function. The multiple regression analysis showed that the PedsQL 4.0 Child Self-Report and PedsQL 4.0 Parent Proxy Report scores were significantly predicted by the CDI and CPRS scores, respectively. CONCLUSION: Our results demonstrate that there are clear differences between the quality of life reported by the patient themselves and that reported by their caregivers. In addition, the findings suggest that it is critical to treat the patients' accompanying depressive symptoms.
Adolescent
;
Anxiety
;
Cardiopulmonary Resuscitation
;
Caregivers
;
Child
;
Depression
;
Humans
;
Manifest Anxiety Scale
;
Parents
;
Proxy
;
Quality of Life
4.Expression of Human beta-defensin 2 mRNA by Lipopolysaccharide in Human Corneal Epithelial Cells.
Eon Hee BAE ; Keon Wuk PARK ; Jong Wook KIM ; Byeong Churl JANG ; Ki Jo LIM ; Tae Young JUNG ; Young Kyu KWON ; Sang Woo SHIN ; Sang Pyo KIM ; Jong Hyun PARK ; Taeg Kyu KWON ; Won Ki BAEK ; Min Ho SUH ; Seong Il SUH
Journal of Bacteriology and Virology 2004;34(1):27-38
Recently the transcriptional up-regulation of human beta-defensin 2 (HBD-2) by lipopolysaccharide (LPS) was found to be associated with NF-kappaB binding site. Although the general mechanisms of NF-kappaB activation by LPS stimulation are well understood, less is known about the signal transduction pathway leading to LPS-induced NF-kappaB activation in human corneal epithelial (HCE) cells. The aim of this study was to investigate the intracellular signals involved in LPS-induced HBD-2 mRNA expression in HCE cells. Pretreatments of inhibitors for NF-kappaB, protein tyrosine kinase, p38 mitogen activated protein kinase (MAPK), and c-Jun N-terminal kinase (JNK) attenuated the LPS-induced NF-kappaB DNA binding activity and HBD-2 mRNA expression. Furthermore, pretreatments with inhibitors for protein kinase C (PKC), phosphatidylcholine-phospholipase C, phosphatidylinositol-phospholipase C, or phosphatidate phosphohydrolase prevented LPS-induced HBD-2 mRNA expression and HBD-2 prmoter-driven luciferase activity. However, the increased expression of HBD-2 mRNA and the increased DNA binding activity of NF-kappaB induced by LPS were not changed by the blockage of extracellular signal-regulated kinase (ERK) and of addition of antioxidants. Forskolin, a protein kinase A (PKA) agonist did not induce HBD-2 mRNA expression. These data demonstrate that LPS-induced HBD-2 mRNA expression via NF-kappaB is, at least in part, dependent on PKC, p38 MAPK, JNK, and protein tyrosine kinase status, but appears to be independent on PKA, ERK and ROS in HCE cells. Taken together, there may be more than one signaling pathways that lead to LPS-induced up-regulation of HBD-2 mRNA expression in HCE cells.
Antioxidants
;
Binding Sites
;
Colforsin
;
Cyclic AMP-Dependent Protein Kinases
;
DNA
;
Epithelial Cells*
;
Humans*
;
JNK Mitogen-Activated Protein Kinases
;
Luciferases
;
NF-kappa B
;
p38 Mitogen-Activated Protein Kinases
;
Phosphatidate Phosphatase
;
Phosphotransferases
;
Protein Kinase C
;
Protein Kinases
;
Protein-Tyrosine Kinases
;
RNA, Messenger*
;
Signal Transduction
;
Up-Regulation
5.Rectourethral Fistula: Systemic Review of and Experiences With Various Surgical Treatment Methods.
Ji Hye CHOI ; Byeong Geon JEON ; Sang Gi CHOI ; Eon Chul HAN ; Heon Kyun HA ; Heung Kwon OH ; Eun Kyung CHOE ; Sang Hui MOON ; Seung Bum RYOO ; Kyu Joo PARK
Annals of Coloproctology 2014;30(1):35-41
PURPOSE: A rectourethral fistula (RUF) is an uncommon complication resulting from surgery, radiation or trauma. Although various surgical procedures for the treatment of an RUF have been described, none has gained acceptance as the procedure of choice. The aim of this study was to review our experience with surgical management of RUF. METHODS: The outcomes of 6 male patients (mean age, 51 years) with an RUF who were operated on by a single surgeon between May 2005 and July 2012 were assessed. RESULTS: The causes of the RUF were iatrogenic in four cases (two after radiation therapy for rectal cancer, one after brachytherapy for prostate cancer, and one after surgery for a bladder stone) and traumatic in two cases. Fecal diversion was the initial treatment in five patients. In one patient, fecal diversion was performed simultaneously with definitive repair. Four patients underwent staged repair after a mean of 12 months. Rectal advancement flaps were done for simple, small fistula (n = 2), and flap interpositions (gracilis muscle flap, n = 2; omental flap, n = 1) were done for complex or recurrent fistulae. Urinary strictures and incontinence were observed in patients after gracilis muscle flap interposition, but they were resolved with simple treatments. The mean follow-up period was 28 months, and closure of the fistula was achieved in all five patients (100%) who underwent definitive repairs. The fistula persisted in one patient who refused further definitive surgery after receiving only a fecal diversion. CONCLUSION: Depending on the severity and the recurrence status of RUF, a relatively simple rectal advancement flap repair or a more complex gracilis muscle or omental flap interposition can be used to achieve closure of the fistula.
Brachytherapy
;
Constriction, Pathologic
;
Fistula*
;
Follow-Up Studies
;
Humans
;
Male
;
Muscles
;
Prostatic Neoplasms
;
Rectal Fistula
;
Rectal Neoplasms
;
Recurrence
;
Surgical Flaps
;
Urinary Bladder
;
Urinary Fistula
6.Efficacy and Safety Profile of Risperidone in Schizophrenia: Open Multicenter Clinical Trial.
Min Soo LEE ; Yong Ku KIM ; Young Hoon KIM ; Byeong Kil YEON ; Byoung Hoon OH ; Doh Joon YOON ; Jin Sang YOON ; Chul LEE ; Hee Yeon JEOUNG ; Byung Jo KANG ; Kwang Soo KIM ; Dong Eon KIM ; Myung Jung KIM ; Sang Hun KIM ; Hee Cheol KIM ; Chul NA ; Seung Ho RHO ; Kyung Joon MIN ; Ki Chang PARK ; Doo Byung PARK ; Ki Chung PAIK ; In Ho PAIK ; Bong Ki SON ; Jin Wook SOHN ; Byung Hwan YANG ; Chang Kook YANG ; Haing Won WOO ; Jung Ho LEE ; Jong Bum LEE ; Hong Shick LEE ; Ki Young LIM ; Tae Youn JUN ; Young Cho CHUNG ; Young Chul CHUNG ; In Kwa JUNG ; In Won CHUNG ; Ik Seung CHEE ; Jeong Ho CHAE ; Sang Ick HAN ; Sun Ho HAN ; Jin Hee HAN ; Kwang Yoon SUH
Journal of Korean Neuropsychiatric Association 1998;37(1):60-74
OBJECTIVE: The purpose of this study was to investigate the efficacy and safety of risperidone in the treatment of Korean schizophrenic patients. METHOD: This multicenter open study included 377 schizophrenic patients drawn from 39 university hospitals. After a wash-out period of 1 week, the schizophrenic patients were treated with risperidone for 8 weeks and evaluated at 5 points: at baseline, and 1,2,4 and 8 weeks of treatment. The dose was increased from 2mg/day(1mg twice daily) to 6mg/day(3mg twice daily) during the first week and adjusted to a maximum of 16mg/day over the next 7 weeks according to the patient's clinical response. Medication to control extrapyramidal symptoms was permitted. The psychiatric and neurological status of the patients was assessed by PANSS, CGI, and ESRS scales. RESULTS: 343(91%) of 377 patients completed the 8-week trial period. Clinical improvement, as defined by a 20% or more reduction in total PANSS score at end point, was shown by 81.3% of patients. The predictors of response to risperidone were associated older age, shorter duration of illness, fewer previous hospitalization. Risperidone had rapid onset of action: a significant decrease of the total PANSS and three PANSS factor(positive, negative, general), and CGI was already noticed at the end of first week. For the ESRS, parkinsonism rating scores were significantly increased until week 4 comparing with baseline. Dystonia rating scores were significantly increased until week 1, and dyskinesia rating scores were not significantly changed during the study. Laboratory parameters including vital sign, EKG, hematological, and biochemical values showed no significant changes during the trial. CONCLUSIONS: This study suggests that risperidone is generally safe and effective against both the positive and negative symptoms in our group of patients.
Dyskinesias
;
Dystonia
;
Electrocardiography
;
Hospitalization
;
Hospitals, University
;
Humans
;
Parkinsonian Disorders
;
Risperidone*
;
Schizophrenia*
;
Vital Signs
;
Weights and Measures